CO5580790A2 - Composicion farmaceutica de fondaparinux sodio para el tratamiento de acs - Google Patents

Composicion farmaceutica de fondaparinux sodio para el tratamiento de acs

Info

Publication number
CO5580790A2
CO5580790A2 CO04030711A CO04030711A CO5580790A2 CO 5580790 A2 CO5580790 A2 CO 5580790A2 CO 04030711 A CO04030711 A CO 04030711A CO 04030711 A CO04030711 A CO 04030711A CO 5580790 A2 CO5580790 A2 CO 5580790A2
Authority
CO
Colombia
Prior art keywords
acs
treatment
pharmaceutical composition
sulfo
phondaparinux
Prior art date
Application number
CO04030711A
Other languages
English (en)
Spanish (es)
Inventor
Anthonie Lensing
Arnold Wilhelmus
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8181220&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO5580790(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of CO5580790A2 publication Critical patent/CO5580790A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CO04030711A 2001-11-13 2004-03-31 Composicion farmaceutica de fondaparinux sodio para el tratamiento de acs CO5580790A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01204323 2001-11-13

Publications (1)

Publication Number Publication Date
CO5580790A2 true CO5580790A2 (es) 2005-11-30

Family

ID=8181220

Family Applications (1)

Application Number Title Priority Date Filing Date
CO04030711A CO5580790A2 (es) 2001-11-13 2004-03-31 Composicion farmaceutica de fondaparinux sodio para el tratamiento de acs

Country Status (36)

Country Link
US (1) US20040248848A1 (enExample)
EP (1) EP1446131B1 (enExample)
JP (1) JP4523276B2 (enExample)
KR (1) KR20050044318A (enExample)
CN (1) CN1602197A (enExample)
AP (1) AP1820A (enExample)
AR (1) AR037291A1 (enExample)
AT (1) ATE361753T1 (enExample)
AU (1) AU2002351915B2 (enExample)
BR (1) BR0212915A (enExample)
CA (1) CA2465776A1 (enExample)
CO (1) CO5580790A2 (enExample)
CY (1) CY1106765T1 (enExample)
DE (1) DE60220084T2 (enExample)
DK (1) DK1446131T3 (enExample)
EA (1) EA007325B1 (enExample)
EC (1) ECSP045041A (enExample)
ES (1) ES2287343T3 (enExample)
GE (1) GEP20074097B (enExample)
HR (1) HRP20040303B1 (enExample)
HU (1) HU228959B1 (enExample)
IL (2) IL161114A0 (enExample)
IS (1) IS2484B (enExample)
MA (1) MA27071A1 (enExample)
ME (2) ME00229B (enExample)
MX (1) MXPA04003045A (enExample)
NO (1) NO20041320L (enExample)
NZ (1) NZ552129A (enExample)
PE (1) PE20030740A1 (enExample)
PL (1) PL206008B1 (enExample)
PT (1) PT1446131E (enExample)
RS (1) RS50906B (enExample)
SI (1) SI1446131T1 (enExample)
UA (1) UA80399C2 (enExample)
WO (1) WO2003041722A1 (enExample)
ZA (1) ZA200402464B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090075910A1 (en) * 2007-09-13 2009-03-19 Protia, Llc Deuterium-enriched fondaparinux
EP3271405A1 (en) * 2015-03-20 2018-01-24 Aarhus Universitet Inhibitors of pcsk9 for treatment of lipoprotein metabolism disorders
US10688249B2 (en) * 2015-06-11 2020-06-23 Virchow Biotech Pvt. Ltd. Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same
CN107595769A (zh) * 2017-10-23 2018-01-19 上海博悦生物科技有限公司 一种磺达肝癸钠注射液组合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662442A1 (fr) * 1990-05-23 1991-11-29 Midy Spa Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant.
CA2199642C (en) * 1997-03-10 2001-05-08 Roger Cariou Compositions containing an association of aspirin and an anti-xa oligosaccharide and use of an anti-xa oligosaccharide optionally in combination with aspirin
FR2764511B1 (fr) * 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire
JP2006501815A (ja) * 2002-04-25 2006-01-19 モメンタ ファーマシューティカルズ インコーポレイテッド 粘膜送達のための方法および製品

Also Published As

Publication number Publication date
US20040248848A1 (en) 2004-12-09
HU228959B1 (en) 2013-07-29
HRP20040303A2 (en) 2004-10-31
RS26704A (sr) 2007-02-05
AP2004003014A0 (en) 2004-06-30
ATE361753T1 (de) 2007-06-15
NO20041320L (no) 2004-06-14
CY1106765T1 (el) 2012-05-23
MA27071A1 (fr) 2004-12-20
KR20050044318A (ko) 2005-05-12
EA007325B1 (ru) 2006-08-25
HRP20040303B1 (hr) 2012-02-29
AP1820A (en) 2008-01-11
MEP1108A (en) 2011-02-10
ME00229B (me) 2011-10-10
MXPA04003045A (es) 2005-06-20
BR0212915A (pt) 2004-10-13
HUP0401462A2 (en) 2006-02-28
JP4523276B2 (ja) 2010-08-11
HK1070561A1 (en) 2005-06-24
CA2465776A1 (en) 2003-05-22
PL369027A1 (en) 2005-04-18
IL161114A (en) 2010-11-30
ZA200402464B (en) 2005-06-29
EP1446131B1 (en) 2007-05-09
AU2002351915B2 (en) 2007-11-29
RS50906B (sr) 2010-08-31
WO2003041722A1 (en) 2003-05-22
CN1602197A (zh) 2005-03-30
DK1446131T3 (da) 2007-09-10
IL161114A0 (en) 2004-08-31
UA80399C2 (en) 2007-09-25
ES2287343T3 (es) 2007-12-16
ECSP045041A (es) 2004-04-28
HUP0401462A3 (en) 2006-04-28
DE60220084T2 (de) 2008-01-10
SI1446131T1 (sl) 2007-10-31
DE60220084D1 (de) 2007-06-21
IS2484B (is) 2008-12-15
JP2005509007A (ja) 2005-04-07
EA200400382A1 (ru) 2004-10-28
NZ552129A (en) 2008-04-30
PL206008B1 (pl) 2010-06-30
EP1446131A1 (en) 2004-08-18
IS7199A (is) 2004-03-29
PE20030740A1 (es) 2003-08-28
PT1446131E (pt) 2007-08-07
AR037291A1 (es) 2004-11-03
GEP20074097B (en) 2007-05-10

Similar Documents

Publication Publication Date Title
CO5160320A1 (es) Metodos y composiciones para la prevencion de tolerancia a medicamentos das.
ES2076935T3 (es) Compuesto de pirazolopiridina y procedimientos para su preparacion.
AR012671A1 (es) Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos
UY26635A1 (es) Métodos sinérgicos y composiciones para el tratamiento del cáncer
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
PA8453201A1 (es) Formulaciones farmaceuticas que contienen voriconazol
CY1114631T1 (el) Φαρμακοτεχνικες μορφες εχινοκανδινης που περιεχουν επιφανειοδραστικα που σχηματιζουν μικκυλιο
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
IT1245761B (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
ES2081531T3 (es) Composiciones farmaceuticas que contienen rifaximina para el tratamiento de infecciones vaginales.
ES2091737T1 (es) Formulados farmaceuticos de fluoxetina.
ES2145774T3 (es) Derivados de adenosina que tienen actividad agonista en a2.
EA199801086A1 (ru) Неводные медицинские средства для очистки толстой кишки
ES2159591T3 (es) Composicion de liberacion controlada.
ES2145557T3 (es) Composiciones de ablandamiento del agua y composiciones detergentes.
AR033688A1 (es) Composicion parenteral reconstituible
BR0112080A (pt) Vetores particulados para aperfeiçoamento da absorção oral de principios ativos
DK0538011T3 (da) Saltsammensætninger omfattende lipofilt oligosaccharidantibiotikum.
MX9706957A (es) Composicion que contiene amlodipina, o una sal, o felodipina y un inhibidor de enzima convertidora de angiotensina.
NO304113B1 (no) Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament
CO5190674A1 (es) Tratamiento de desordenes neuroticos desordenes neuroticos
CO5540294A2 (es) Una combinacion de un derivado de rapamicina y un agente alquilante seleccionado de ciclofosfamida y carmustina y composiciones que las contienen
DK0930077T3 (da) Cyclodextrinpræparater indeholdende et avermectin- eller milbemycinderivat
ATE261425T1 (de) Erythromycin-derivate mit antibiotischer wirkung
CO5580790A2 (es) Composicion farmaceutica de fondaparinux sodio para el tratamiento de acs

Legal Events

Date Code Title Description
FC Application refused